HK1206097A1 - Identification of patients with abnormal fractional shortening - Google Patents

Identification of patients with abnormal fractional shortening

Info

Publication number
HK1206097A1
HK1206097A1 HK15106518.3A HK15106518A HK1206097A1 HK 1206097 A1 HK1206097 A1 HK 1206097A1 HK 15106518 A HK15106518 A HK 15106518A HK 1206097 A1 HK1206097 A1 HK 1206097A1
Authority
HK
Hong Kong
Prior art keywords
patients
identification
fractional shortening
abnormal
abnormal fractional
Prior art date
Application number
HK15106518.3A
Other languages
English (en)
Chinese (zh)
Inventor
Dirk Block
Serge Masson
Ursula-Henrike Wienhues-Thelen
Christian Zaugg
Roberto Latini
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1206097A1 publication Critical patent/HK1206097A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A61B8/0883—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of the heart
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/329—Diseases of the aorta or its branches, e.g. aneurysms, aortic dissection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
HK15106518.3A 2012-09-12 2015-07-08 Identification of patients with abnormal fractional shortening HK1206097A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12184085 2012-09-12
PCT/EP2013/056706 WO2014040759A1 (fr) 2012-09-12 2013-03-28 Identification de patients à fraction de raccourcissement anormale

Publications (1)

Publication Number Publication Date
HK1206097A1 true HK1206097A1 (en) 2015-12-31

Family

ID=46826365

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106518.3A HK1206097A1 (en) 2012-09-12 2015-07-08 Identification of patients with abnormal fractional shortening

Country Status (8)

Country Link
US (3) US20150185230A1 (fr)
EP (3) EP4075143A1 (fr)
JP (2) JP6247302B2 (fr)
CN (1) CN104620111B (fr)
CA (1) CA2883890C (fr)
ES (2) ES2913539T3 (fr)
HK (1) HK1206097A1 (fr)
WO (1) WO2014040759A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3088900B1 (fr) 2011-10-17 2020-08-12 Roche Diagniostics GmbH Troponin comme marqueur de la fibrillation auriculaire intermittente
EP3413052B1 (fr) 2014-03-26 2022-12-28 Roche Diagnostics GmbH Igfbp7 permettant de diagnostiquer un dysfonctionnement diastolique
CN107110871B (zh) 2014-10-29 2019-09-27 豪夫迈·罗氏有限公司 用于死亡的风险预测的生物标志物
ES2774967T3 (es) 2015-10-08 2020-07-23 Hoffmann La Roche IGFBP7 para la predicción del riesgo de LRA cuando se mide antes de una intervención quirúrgica
WO2017125406A1 (fr) * 2016-01-19 2017-07-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes de prédiction de remodelage ventriculaire gauche chez des sujets souffrant d'hypertension
BR112019025387A2 (pt) * 2017-05-30 2020-07-07 Abbott Laboratories métodos para auxiliar no diagnóstico e avaliação de uma lesão traumática cerebral branda em um indivíduo humano com o uso de troponina cardíaca i e biomarcadores precoces
BR112020011454A2 (pt) 2017-12-13 2021-02-09 F. Hoffmann-La Roche Ag métodos para prever o risco de acidente vascular, para prever o risco de acidente vascular cerebral e para aprimorar a precisão da previsão e usos do (i) biomarcador ang-2 e/ou do biomarcador igfbp7
JP7024576B2 (ja) * 2018-04-20 2022-02-24 オムロンヘルスケア株式会社 電子血圧計および心不全検出器
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US6709855B1 (en) 1998-12-18 2004-03-23 Scios, Inc. Methods for detection and use of differentially expressed genes in disease states
WO2002075302A1 (fr) * 2001-03-15 2002-09-26 Xiao Yong Fu Methode de traitement therapeutique d'une forme cliniquement identifiee de cardiopathie chez un mammifere vivant
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US7632647B2 (en) 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
EP1666881B1 (fr) * 2001-05-04 2010-02-17 Biosite Incorporated Marqueurs de diagnostic de syndrome coronarien aigu et leurs procédés d'utilisation
AU2002348289A1 (en) * 2001-11-19 2003-06-10 Protometrix, Inc. Method of using a non-antibody protein to detect and measure an analyte
JP2005291899A (ja) * 2004-03-31 2005-10-20 Akira Matsumori 心疾患の検査法
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
US20080027330A1 (en) * 2006-05-15 2008-01-31 Endothelix, Inc. Risk assessment method for acute cardiovascular events
WO2008060618A2 (fr) * 2006-11-15 2008-05-22 University Of Florida Research Foundation Utilisation de déterminants génétiques dans l'évaluation d'un risque cardiovasculaire
WO2008089994A1 (fr) 2007-01-25 2008-07-31 Roche Diagnostics Gmbh Utilisation de igfbp-7 dans l'évaluation d'une insuffisance cardiaque
AU2008246125B2 (en) * 2007-04-26 2013-01-24 Genera Istrazivanja D.O.O. Blood biomarkers for bone fracture and cartilage injury
EP2515116A1 (fr) 2007-05-18 2012-10-24 Duke University Biomarqueurs sériques pour la détection précoce du cancer du poumon
US20110183434A1 (en) * 2008-01-17 2011-07-28 Myles Wolf Diagnostic methods and kits using fibroblast growth factor-23
US20120010094A1 (en) * 2008-11-06 2012-01-12 Musc Foundation For Research Development Detecting and monitoring left ventricular hypertrophy and congestive heart failure by profiling biomarkers
JP2012522746A (ja) 2009-04-01 2012-09-27 レツク・フアーマシユーテイカルズ・デー・デー 活性メチレン基のジメチル化の方法
ES2607491T3 (es) * 2009-04-27 2017-03-31 F. Hoffmann-La Roche Ag Uso de endostatina como marcador de la insuficiencia cardíaca
CN102549436A (zh) 2009-07-27 2012-07-04 霍夫曼-拉罗奇有限公司 mimecan在评价心力衰竭中的用途
CN102725636B (zh) * 2009-12-20 2015-04-01 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
WO2011117371A2 (fr) * 2010-03-26 2011-09-29 Pronota N.V. Ltbp2 en tant que biomarqueur d'un dysfonctionnement rénal
US20120142632A1 (en) * 2010-08-04 2012-06-07 St. Vincent's Institute Of Medical Research Diagnostic and prognostic assay
EP3225994A1 (fr) * 2010-08-26 2017-10-04 Roche Diagnostics GmbH Utilisation de biomarqueurs pour l'évaluation d'une transition précoce d'hypertension artérielle vers une insuffisance cardiaque
EP3578979B1 (fr) * 2010-08-31 2022-02-23 Minaris Medical Co., Ltd. Procédé de mesure du facteur-23 de croissance des fibroblastes et réactif associé

Also Published As

Publication number Publication date
JP6615848B2 (ja) 2019-12-04
JP2018049032A (ja) 2018-03-29
CN104620111B (zh) 2017-08-08
EP3428649A2 (fr) 2019-01-16
EP3428649B1 (fr) 2022-03-23
CN104620111A (zh) 2015-05-13
EP3428649A3 (fr) 2019-02-13
JP2015531873A (ja) 2015-11-05
WO2014040759A1 (fr) 2014-03-20
JP6247302B2 (ja) 2017-12-13
EP4075143A1 (fr) 2022-10-19
CA2883890C (fr) 2021-11-09
ES2680149T3 (es) 2018-09-04
US11454634B2 (en) 2022-09-27
US20180196067A1 (en) 2018-07-12
EP2895866B1 (fr) 2018-05-30
CA2883890A1 (fr) 2014-03-20
US20220412991A1 (en) 2022-12-29
ES2913539T3 (es) 2022-06-02
EP2895866A1 (fr) 2015-07-22
US20150185230A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
IL272915B (en) syringe
HK1206097A1 (en) Identification of patients with abnormal fractional shortening
HK1202816A1 (en) Syringe
GB201218307D0 (en) Patient monitor
EP2832391A4 (fr) Seringue
ZA201406082B (en) Use of ccr3-inhibitors
GB2500092B (en) Syringe
HK1251496A1 (zh) 注射器
EP2913076A4 (fr) Seringue
GB201205189D0 (en) Novel medical use
GB201215502D0 (en) Medical use
TWM433206U (en) Safety syringe
GB2515701B (en) Safety scalpel
GB201215621D0 (en) Medical solution
GB201216381D0 (en) New compounds and medical uses
EP2885023A4 (fr) Seringue
GB201208970D0 (en) New compounds and medical uses
GB201222517D0 (en) Organism monitoring